Piper Sandler Trims CONMED (NYSE:CNMD) Target Price to $95.00

CONMED (NYSE:CNMD – Free Report) had its target price trimmed by Piper Sandler from $100.00 to $95.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Several other analysts have also issued reports on the company. Needham & Company LLC dropped their price objective […]

Leave a Reply

Your email address will not be published.

Previous post Evercore ISI Trims Knight-Swift Transportation (NYSE:KNX) Target Price to $55.00
Next post Roth Capital Weighs in on Meta Platforms, Inc.’s Q3 2024 Earnings (NASDAQ:META)